Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol.

Katie AndresenEmma CuttingDimitrios ApostolopoulosAmy H EvansLaura OakleyAlimu DayimuNikolaos DemirisKatherine BongaertsRobyn StaplesWendy GoodingDavid RubinszteinRoger A Barker

Published in: BMJ open (2024)

EudraCT-2021-000897-27, ISRCTN56240656.

Keyphrases

phase ii
open label
phase iii
clinical trial
phase ii study
study protocol
placebo controlled
double blind
randomized controlled trial
endoplasmic reticulum stress
locally advanced